NCT06253195 BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT06246968 A Study of Pembrolizumab and Cryoablation in People With Breast Cancer Status RECRUITING Phase PHASE1
NCT06214793 Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) Status SUSPENDED Phase PHASE2
NCT06202261 A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06161181 Enhancing Therapy Adherence Among Metastatic Breast Cancer Patients Status COMPLETED Phase NA
NCT06157892 A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06154590 Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor Status NOT_YET_RECRUITING Phase N/A
NCT06151249 Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving Chemotherapy Status NOT_YET_RECRUITING Phase PHASE2
NCT06145399 A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer Status WITHDRAWN Phase EARLY_PHASE1
NCT06135714 Metastasis-directed Therapy for Oligometastases of Breast Cancer Status RECRUITING Phase PHASE3
NCT06120283 BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06110793 A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06106711 The Impact of Adverse Events, Produced by Antibodies Conjugates, on Quality of Life in Patients With Metastatic Breast Cancer: Multicentric, Observational Study (EVA). Status UNKNOWN Phase N/A
NCT06105684 Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer Status RECRUITING Phase PHASE2
NCT06099769 A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT06083038 Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib Status COMPLETED Phase N/A
NCT06081959 Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer Status RECRUITING Phase PHASE3